# Rain Enhancement Technologies Holdco, Inc.: financial statements, quarterly

RAIN · Nasdaq · CIK 2028293 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rain.md) · [Financials](/companies/rain/financials.md) · [Filings](/companies/rain/filings.md) · [Insiders](/companies/rain/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rain/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [10.5](/filings/0001213900-26-057838.md) | [0.0 d](/filings/0001213900-26-090166.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | [46.2](/filings/0001213900-25-110062.md) | [14.3 d](/filings/0001213900-26-044121.md) | [40.7](/filings/0001213900-26-057838.md) | [31.9](/filings/0001213900-26-090166.md) |
| Operating income | $k | [(23.9)](/filings/0001213900-25-044438.md) | [(317)](/filings/0001213900-25-076727.md) | [(3,000)](/filings/0001213900-25-110062.md) | [(1,162) d](/filings/0001213900-26-044121.md) | [(1,345)](/filings/0001213900-26-057838.md) | [(1,073)](/filings/0001213900-26-090166.md) | [(1,644)](/filings/0001213900-25-110062.md) | [(4,070) d](/filings/0001213900-26-044121.md) | [(1,926)](/filings/0001213900-26-057838.md) | [(3,057)](/filings/0001213900-26-090166.md) |
| Interest expense | $k | not reported | not reported | [7.5](/filings/0001213900-25-110062.md) | [8.0 d](/filings/0001213900-26-044121.md) | [47.1](/filings/0001213900-26-057838.md) | [33.1](/filings/0001213900-26-090166.md) | [243](/filings/0001213900-25-110062.md) | [(38.9) d](/filings/0001213900-26-044121.md) | [139](/filings/0001213900-26-057838.md) | [310](/filings/0001213900-26-090166.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0001213900-25-076727.md) | [0.0 d](/filings/0001213900-25-110062.md) | [0.0 d](/filings/0001213900-26-044121.md) | not reported | not reported |
| Net income | $k | [(31.3)](/filings/0001213900-25-110062.md) | [(325)](/filings/0001213900-25-110062.md) | [(3,008)](/filings/0001213900-25-110062.md) | [(1,170) d](/filings/0001213900-26-044121.md) | [(1,482)](/filings/0001213900-26-090166.md) | [(953)](/filings/0001213900-26-090166.md) | [(2,200)](/filings/0001213900-25-110062.md) | [(4,456) d](/filings/0001213900-26-044121.md) | [(1,860)](/filings/0001213900-26-090166.md) | [(3,247)](/filings/0001213900-26-090166.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | [0.0](/filings/0001213900-25-044438.md) | [0.3](/filings/0001213900-25-044438.md) | [0.0](/filings/0001213900-25-076727.md) | [0.2](/filings/0001213900-25-110062.md) | [0.2](/filings/0001213900-26-090166.md) | [0.6](/filings/0001213900-26-057838.md) | [0.0](/filings/0001213900-26-090166.md) |
| Current assets | $m | [0.0](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | [0.8](/filings/0001213900-26-044121.md) | [1.1](/filings/0001213900-26-044121.md) | [0.7](/filings/0001213900-26-044121.md) | [0.6](/filings/0001213900-25-110062.md) | [0.3](/filings/0001213900-26-090166.md) | [1.1](/filings/0001213900-26-057838.md) | [0.4](/filings/0001213900-26-090166.md) |
| Total assets | $m | [0.5](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | [1.3](/filings/0001213900-26-044121.md) | [1.7](/filings/0001213900-26-044121.md) | [1.8](/filings/0001213900-26-044121.md) | [1.9](/filings/0001213900-25-110062.md) | [1.8](/filings/0001213900-26-090166.md) | [2.6](/filings/0001213900-26-057838.md) | [2.4](/filings/0001213900-26-090166.md) |
| Current liabilities | $m | [1.2](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | [6.2](/filings/0001213900-26-044121.md) | [8.0](/filings/0001213900-26-044121.md) | [9.0](/filings/0001213900-26-044121.md) | [10.7](/filings/0001213900-25-110062.md) | [13.3](/filings/0001213900-26-090166.md) | [15.9](/filings/0001213900-26-057838.md) | [13.6](/filings/0001213900-26-090166.md) |
| Total liabilities | $m | [1.2](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | [6.6](/filings/0001213900-26-044121.md) | [8.5](/filings/0001213900-26-044121.md) | [9.5](/filings/0001213900-26-044121.md) | [11.5](/filings/0001213900-25-110062.md) | [14.5](/filings/0001213900-26-090166.md) | [17.0](/filings/0001213900-26-057838.md) | [14.6](/filings/0001213900-26-090166.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.8](/filings/0001213900-25-032239.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(0.6)](/filings/0001213900-26-044121.md) | [(0.7)](/filings/0001213900-25-110062.md) | [(1.0)](/filings/0001213900-25-110062.md) | [(0.8)](/filings/0001213900-25-110062.md) | [(5.3)](/filings/0001213900-26-090166.md) | [(6.8)](/filings/0001213900-26-090166.md) | [(7.7)](/filings/0001213900-26-090166.md) | [(9.6)](/filings/0001213900-25-110062.md) | [(12.7)](/filings/0001213900-26-090166.md) | [(14.3)](/filings/0001213900-26-090166.md) | [(12.2)](/filings/0001213900-26-090166.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [12.8](/filings/0001213900-25-044438.md) | [(59.2) d](/filings/0001213900-25-076727.md) | [(120) d](/filings/0001213900-25-110062.md) | [(1,156) d](/filings/0001213900-26-044121.md) | [(1,007)](/filings/0001213900-26-057838.md) | [(383) d](/filings/0001213900-26-090166.md) | [(234) d](/filings/0001213900-25-110062.md) | [(329) d](/filings/0001213900-26-044121.md) | [(1,874)](/filings/0001213900-26-057838.md) | [(1,025) d](/filings/0001213900-26-090166.md) |
| Capital expenditure | $k | [41.3](/filings/0001213900-25-044438.md) | [3.4 d](/filings/0001213900-25-076727.md) | [1.1 d](/filings/0001213900-25-110062.md) | [0.0 d](/filings/0001213900-26-044121.md) | [139](/filings/0001213900-26-057838.md) | [473 d](/filings/0001213900-26-090166.md) | [246 d](/filings/0001213900-25-110062.md) | [129 d](/filings/0001213900-26-044121.md) | [9.5](/filings/0001213900-26-057838.md) | [0.0 d](/filings/0001213900-26-090166.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.